Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in Radiother Oncol

Retrieve available abstracts of 256 articles:
HTML format



Single Articles


    July 2022
  1. PRICE JM, West CM, Dixon LM, Iyizoba-Ebozue Z, et al
    Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study.
    Radiother Oncol. 2022;172:111-117.
    PubMed     Abstract available


  2. WANG J, Liu Y, Shayan G, Ma Y, et al
    Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
    Radiother Oncol. 2022;172:83-90.
    PubMed     Abstract available


  3. NIU X, Liu P, Zhou X, Wang X, et al
    Is postoperative radiotherapy an essential treatment for nonmetastatic lymphoepithelial carcinoma of the salivary gland?
    Radiother Oncol. 2022;172:76-82.
    PubMed     Abstract available


  4. FRIED DV, Zhu T, Das SK, Shen C, et al
    Prospective assessment of sparing the parotid ducts via MRI sialography for reducing patient reported xerostomia.
    Radiother Oncol. 2022;172:42-49.
    PubMed     Abstract available


  5. HOFFMANN L, Mortensen H, Shamshad M, Berbee M, et al
    Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres.
    Radiother Oncol. 2022;172:32-41.
    PubMed     Abstract available


    June 2022
  6. QIAN D, Chen X, Shang X, Wang Y, et al
    Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II rando
    Radiother Oncol. 2022 Jun 25. pii: S0167-8140(22)04176.
    PubMed     Abstract available


  7. KROESE TE, Christ SM, van Rossum PSN, Burger MDL, et al
    Incidence and survival of patients with oligometastatic esophagogastric cancer: a multicenter cohort study.
    Radiother Oncol. 2022 Jun 23. pii: S0167-8140(22)04173.
    PubMed     Abstract available


  8. GONG J, Zhang W, Huang W, Liao Y, et al
    CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: a multicenter study.
    Radiother Oncol. 2022 Jun 21. pii: S0167-8140(22)04171.
    PubMed     Abstract available


  9. HANSEN CR, Price G, Field M, Sarup N, et al
    Open-source distributed learning validation for a larynx cancer survival model following radiotherapy.
    Radiother Oncol. 2022 Jun 20. pii: S0167-8140(22)04170.
    PubMed     Abstract available


  10. FU G, Xie Y, Pan J, Qiu Y, et al
    Longitudinal study of irradiation-induced brain functional network alterations in patients with nasopharyngeal carcinoma.
    Radiother Oncol. 2022 Jun 16. pii: S0167-8140(22)04164.
    PubMed     Abstract available


  11. SCHOONBEEK RC, Festen S, van der Laan BFAM, Plaat BEC, et al
    The effect of delayed treatment initiation on adverse events and recurrence in older head and neck cancer patients.
    Radiother Oncol. 2022 Jun 6. pii: S0167-8140(22)04146.
    PubMed     Abstract available


  12. MASSACCESI M, Dinapoli N, Fuga V, Rupe C, et al
    A predictive nomogram for trismus after radiotherapy for head and neck cancer.
    Radiother Oncol. 2022 Jun 2. pii: S0167-8140(22)04137.
    PubMed     Abstract available


  13. PATIL S, Linge A, Grosser M, Lohaus F, et al
    Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy.
    Radiother Oncol. 2022;171:91-100.
    PubMed     Abstract available


    May 2022
  14. ZHAO DW, Fan WJ, Fang XM, Luo YR, et al
    Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging.
    Radiother Oncol. 2022 May 15. pii: S0167-8140(22)00251.
    PubMed     Abstract available


  15. YI-LIANG SHEN E, Hung TM, Tsan DL, Cheng NM, et al
    Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating epstein-barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma.
    Radiother Oncol. 2022 May 11. pii: S0167-8140(22)00240.
    PubMed     Abstract available


  16. BIAU J, Nutting C, Langendijk JA, Frederic-Moreau T, et al
    Radiographic-anatomy, natural history and extension pathways of parotid and submandibular gland cancers.
    Radiother Oncol. 2022;170:48-54.
    PubMed     Abstract available


  17. SOOKAROMDEE P, Wiwanitkit V
    Comment on "Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC".
    Radiother Oncol. 2022;170:250.
    PubMed    


  18. LOCK S, Baumann M
    Response to comment on "Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC".
    Radiother Oncol. 2022;170:251.
    PubMed    


  19. PERGOLIZZI S, Ferini G, Parisi S
    Letter to the editor of radiotherapy and oncology regarding of the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
    Radiother Oncol. 2022;170:247.
    PubMed    


  20. KARAM I, Voruganti IS, Poon I
    Response letter to the Editor of Radiotherapy and Oncology regarding the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
    Radiother Oncol. 2022;170:248-249.
    PubMed    


    April 2022
  21. ZHAO Y, Liao X, Wang Y, Lan W, et al
    Level Ib CTV delineation in nasopharyngeal carcinoma based on lymph node distribution and topographic anatomy.
    Radiother Oncol. 2022 Apr 29. pii: S0167-8140(22)00232.
    PubMed     Abstract available


  22. DOHOPOLSKI M, Wang K, Morgan H, Sher D, et al
    Predicting the need for aggressive nutritional supplementation in head and neck cancer patients receiving radiation therapy.
    Radiother Oncol. 2022 Apr 21. pii: S0167-8140(22)00224.
    PubMed     Abstract available


  23. SHEN H, Yin J, Niu R, Lian Y, et al
    Development and validation of a radiomic nomogram to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carc
    Radiother Oncol. 2022 Apr 21. pii: S0167-8140(22)00222.
    PubMed     Abstract available


  24. LEE BM, Lee CG
    Significance of mid-radiotherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography in esophageal cancer.
    Radiother Oncol. 2022 Apr 18. pii: S0167-8140(22)00191.
    PubMed     Abstract available


  25. WELZ S, Paulsen F, Pfannenberg C, Reimold M, et al
    Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [(18)F]FMISO PET/CT.
    Radiother Oncol. 2022 Apr 5. pii: S0167-8140(22)00170.
    PubMed     Abstract available


  26. JENSEN KH, Vogelius IR, Bernsdorf M, Gothelf A, et al
    Early non-cancer mortality risk prediction after curative-intent radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma.
    Radiother Oncol. 2022 Apr 5. pii: S0167-8140(22)00169.
    PubMed     Abstract available


  27. MULLER J, Leger S, Zwanenburg A, Suckert T, et al
    Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting.
    Radiother Oncol. 2022;169:96-104.
    PubMed     Abstract available


  28. LOCK S, Linge A, Lohaus F, Ebert N, et al
    Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - Hypothesis generation on a multicentre cohort of the DKTK-ROG.
    Radiother Oncol. 2022;169:8-14.
    PubMed     Abstract available


  29. ZHU J, Tan Y, Wang Q
    Letter to the editor regarding the article "Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma - A systematic review and meta-analysis" by Chow et al.
    Radiother Oncol. 2022;169:152-153.
    PubMed    


  30. LUDWIG R, Hoffmann JM, Pouymayou B, Dappen MB, et al
    Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface.
    Radiother Oncol. 2022;169:1-7.
    PubMed     Abstract available


  31. KAO YS, Chen YF
    Comment to "Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma - A systematic review and meta-analysis".
    Radiother Oncol. 2022;169:163.
    PubMed    


    March 2022
  32. YUE M, Xue X, Wang Z, Lambo RL, et al
    Dose prediction via distance-guided deep learning: initial development for nasopharyngeal carcinoma radiotherapy.
    Radiother Oncol. 2022 Mar 26. pii: S0167-8140(22)00150.
    PubMed     Abstract available


  33. BORDERIAS-VILLARROEL E, Taasti V, Van Elmpt W, Teruel-Rivas S, et al
    Evaluation of the clinical value of automatic online dose restoration for adaptive proton therapy of head and neck cancer.
    Radiother Oncol. 2022 Mar 25. pii: S0167-8140(22)00149.
    PubMed     Abstract available


  34. KARAVOLIA E, van Rijn-Dekker MI, Van den Bosch L, van den Hoek JGM, et al
    Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients.
    Radiother Oncol. 2022 Mar 15. pii: S0167-8140(22)00145.
    PubMed     Abstract available


  35. ZHOU X, Wang W, Zhou C, Zhu J, et al
    Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis.
    Radiother Oncol. 2022 Mar 11. pii: S0167-8140(22)00132.
    PubMed     Abstract available


  36. HUANG CC, Lai YR, Chiu WC, Fang FM, et al
    Concurrent chemoradiation therapy is associated with an accelerated risk of cardiovascular autonomic dysfunction in patients with nasopharyngeal carcinoma: A 9-year prospective follow-up study.
    Radiother Oncol. 2022 Mar 11. pii: S0167-8140(22)00129.
    PubMed     Abstract available


  37. CHOW R, Simone CB 2nd
    Radiation induced lymphopenia in head and neck cancer: The importance of rigorous statistical analysis, radiation field size, and treatment modality.
    Radiother Oncol. 2022 Mar 10. pii: S0167-8140(22)00112.
    PubMed    


  38. DAI D, Tian Q, Shui Y, Li J, et al
    Response to "Radiation induced lymphopenia in head and neck cancer: The importance of rigorous statistical analysis, radiation field size, and treatment modality".
    Radiother Oncol. 2022 Mar 10. pii: S0167-8140(22)00109.
    PubMed    


  39. NACHANKAR A, Musha A, Kubo N, Kawamura H, et al
    Dosimetric analysis of intraocular hemorrhage in nonsquamous head and neck cancers treated with carbon-ion radiotherapy.
    Radiother Oncol. 2022 Mar 4. pii: S0167-8140(22)00118.
    PubMed     Abstract available


  40. NORTH VS, Tran AQ, Kazim M
    Orbital adenoid cystic carcinoma arising from nasopharyngeal salivary gland origin.
    Radiother Oncol. 2022;168:104-105.
    PubMed    


  41. GORPHE P, Classe M, Ammari S, Garcia G, et al
    Patterns of disease events and causes of death in patients with HPV-positive versus HPV-negative oropharyngeal carcinoma.
    Radiother Oncol. 2022;168:40-45.
    PubMed     Abstract available


    February 2022
  42. BONOMO P, Desideri I, Mangoni M, Saieva C, et al
    Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: a phase 1/2 trial.
    Radiother Oncol. 2022 Feb 11. pii: S0167-8140(22)00091.
    PubMed     Abstract available


  43. SCANDURRA D, Meijer TWH, Free J, van den Hoek JGM, et al
    Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2022 Feb 5. pii: S0167-8140(22)00080.
    PubMed     Abstract available


  44. PAN D, Rong X, Zhu Y, Ng WT, et al
    A novel nomogram to predict overall survival in head and neck cancer survivors with radiation-induced brain necrosis.
    Radiother Oncol. 2022 Feb 1. pii: S0167-8140(22)00060.
    PubMed     Abstract available


  45. PATIL S, Tawk B, Grosser M, Lohaus F, et al
    Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy.
    Radiother Oncol. 2022;167:300-307.
    PubMed     Abstract available


  46. TAMBAS M, van der Laan HP, Steenbakkers RJHM, Doyen J, et al
    Current practice in proton therapy delivery in adult cancer patients across Europe.
    Radiother Oncol. 2022;167:7-13.
    PubMed     Abstract available


  47. CHANG CW, Wang C, Lu CJ, Wang CW, et al
    Incidence and prognostic significance of extranodal extension in isolated nodal recurrence of oral squamous cell carcinoma.
    Radiother Oncol. 2022;167:81-88.
    PubMed     Abstract available


    January 2022
  48. SUN XS, Zhu MY, Wen DX, Luo DH, et al
    Establishment and validation of a recursive partitioning analysis based prognostic model for guiding re-radiotherapy in local recurrence nasopharyngeal carcinoma patients.
    Radiother Oncol. 2022 Jan 28. pii: S0167-8140(22)00028.
    PubMed     Abstract available


  49. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Head and neck cancer diagnoses and faster treatment initiation during COVID-19: correspondence.
    Radiother Oncol. 2022 Jan 28. pii: S0167-8140(22)00026.
    PubMed    


  50. SCHOONBEEK RC, de Jel DVC, van Dijk BAC, Willems SM, et al
    Response to "Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence".
    Radiother Oncol. 2022 Jan 28. pii: S0167-8140(22)00033.
    PubMed    


  51. CHATTERJEE S, Maulik S, Prasath S, Arun B, et al
    Xerostomia quality of life and resource requirements following parotid sparing adaptive radiotherapy in head and neck cancers: Results of a prospective cohort study (Study ID CTRI/2017/11/010683).
    Radiother Oncol. 2022 Jan 27. pii: S0167-8140(22)00024.
    PubMed     Abstract available


  52. ZECH HB, Berger J, Mansour WY, Nordquist L, et al
    Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer.
    Radiother Oncol. 2022 Jan 27. pii: S0167-8140(22)00022.
    PubMed     Abstract available


  53. AL-MAMGANI A, Kessels R, Janssen T, Navran A, et al
    The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6mm in head and neck squamous cell carcinoma: significant acute and late toxicity reduction.
    Radiother Oncol. 2022 Jan 20. pii: S0167-8140(22)00017.
    PubMed     Abstract available


  54. HE J, Qian L, Gao J
    Comment on ''Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)".
    Radiother Oncol. 2022 Jan 19. pii: S0167-8140(22)00005.
    PubMed    


  55. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Response to the Comment on ''Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)"by He et al.
    Radiother Oncol. 2022 Jan 19. pii: S0167-8140(22)00006.
    PubMed    


  56. DAI D, Tian Q, Shui Y, Li J, et al
    The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis.
    Radiother Oncol. 2022 Jan 8. pii: S0167-8140(22)00007.
    PubMed     Abstract available


  57. HUANG W, Zhang Q, Wu G, Chen P, et al
    Corrigendum to "DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1alpha, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients" [Radiother Oncol (2021) 164:146-154].
    Radiother Oncol. 2022 Jan 7. pii: S0167-8140(21)09059.
    PubMed    


  58. LIU T, Shen BW, Liu LT, Yang ZC, et al
    Impact of salvage radiotherapy on survival of patients with advanced locally recurrent nasopharyngeal carcinoma: Derivation and validation of a predictive model.
    Radiother Oncol. 2022 Jan 5. pii: S0167-8140(21)09094.
    PubMed     Abstract available


  59. HONG CR, Buckley CD, Wong WW, Anekal PV, et al
    Radiosensitisation of SCCVII tumours and normal tissues in mice by the DNA-dependent protein kinase inhibitor AZD7648.
    Radiother Oncol. 2022;166:162-170.
    PubMed     Abstract available


  60. FORNER LE, Dieleman FJ, Shaw RJ, Kanatas A, et al
    Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1.
    Radiother Oncol. 2022;166:137-144.
    PubMed     Abstract available


  61. WENNERBERG J, Gebre-Medhin M, Nilsson P, Brun E, et al
    Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity - The ARTSCAN 2 study.
    Radiother Oncol. 2022;166:26-32.
    PubMed     Abstract available


    December 2021
  62. GUO Q, Xiao N, Xu H, Zong J, et al
    Rationality of the international guideline's recommendation regarding selective coverage of level Ib in clinical target volume with nasopharyngeal carcinoma: Results from a real-world series.
    Radiother Oncol. 2021 Dec 29. pii: S0167-8140(21)09081.
    PubMed     Abstract available


  63. TANG SQ, Chen L, Li WF, Chan ATC, et al
    Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9,468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial.
    Radiother Oncol. 2021 Dec 28. pii: S0167-8140(21)09077.
    PubMed     Abstract available


  64. SCHOONBEEK RC, de Jel DVC, van Dijk BAC, Willems SM, et al
    Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: a nationwide population-based analysis.
    Radiother Oncol. 2021 Dec 13. pii: S0167-8140(21)09049.
    PubMed     Abstract available


  65. MUSHA A, Hirai C, Kitada Y, Tsunoda A, et al
    Relationship between oral mucositis and the oral bacterial count in patients with head and neck cancer undergoing carbon ion radiotherapy: A prospective study.
    Radiother Oncol. 2021 Dec 10. pii: S0167-8140(21)09054.
    PubMed     Abstract available


  66. BEUKEMA JC, de Groot C, Plukker JTM, Vliegenthart R, et al
    Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: a prospective cross-sectional pilot study.
    Radiother Oncol. 2021 Dec 2. pii: S0167-8140(21)09025.
    PubMed     Abstract available


  67. CHOW R, Murdy K, Vaska M, Lee SL, et al
    Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma - A systematic review and meta-analysis.
    Radiother Oncol. 2021;165:37-43.
    PubMed     Abstract available


  68. VORUGANTI IS, Poon I, Husain ZA, Bayley A, et al
    Stereotactic body radiotherapy for head and neck skin cancer.
    Radiother Oncol. 2021;165:1-7.
    PubMed     Abstract available


    November 2021
  69. KUTZ LM, Abel J, Schweizer D, Tribius S, et al
    Quality of life, HPV-status and phase angle predict survival in head and neck cancer patients under (chemo)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial.
    Radiother Oncol. 2021 Nov 25. pii: S0167-8140(21)09004.
    PubMed     Abstract available


  70. JIN YN, Yang QQ, Li ZQ, Ou XQ, et al
    Development of a Web-based Prognostic Model to Quantify the Survival Benefit of Cumulative Cisplatin Dose during Concurrent Chemoradiotherapy in Childhood Nasopharyngeal Carcinoma.
    Radiother Oncol. 2021 Nov 25. pii: S0167-8140(21)09008.
    PubMed     Abstract available


  71. NISHIBUCHI I, Murakami Y, Kubo K, Imano N, et al
    Temporal Changes and Risk Factors for Esophageal Stenosis after Salvage Radiotherapy in Superficial Esophageal Cancer following Non-Curative Endoscopic Submucosal Dissection.
    Radiother Oncol. 2021 Nov 25. pii: S0167-8140(21)09007.
    PubMed     Abstract available


  72. PATEL V, Kwok J, Burke M, Urbano TG, et al
    Should the HPV positive oropharyngeal cancer patient be considered for a two-stage dental assessment for their radiation treatment?
    Radiother Oncol. 2021;164:232-235.
    PubMed     Abstract available


  73. GAN Y, Langendijk JA, Oldehinkel E, Scandurra D, et al
    A novel semi auto-segmentation method for accurate dose and NTCP evaluation in adaptive head and neck radiotherapy.
    Radiother Oncol. 2021;164:167-174.
    PubMed     Abstract available


  74. RUI M, Zhang X, Huang J, Wei D, et al
    The baseline oral microbiota predicts the response of locally advanced oral squamous cell carcinoma patients to induction chemotherapy: A prospective longitudinal study.
    Radiother Oncol. 2021;164:83-91.
    PubMed     Abstract available


    October 2021
  75. BROOKER RC, Antczak P, Liloglou T, Risk JM, et al
    Genetic variants associated with mandibular osteoradionecrosis following radiotherapy for head and neck malignancy.
    Radiother Oncol. 2021;165:87-93.
    PubMed     Abstract available


  76. CHIN O, Yu E, O'Sullivan B, Su J, et al
    Prognostic Importance of Radiologic Extranodal Extension in Nasopharyngeal Carcinoma Treated in a Canadian Cohort.
    Radiother Oncol. 2021 Oct 27. pii: S0167-8140(21)08785.
    PubMed     Abstract available


  77. ZHANG ZM, Zhao R, Bao Y, Zhou LX, et al
    A novel technique of endonasopharyngeal ultrasound-guided transnasopharyngeal needle aspiration in the diagnosis of submucosal recurrence of nasopharyngeal carcinoma after chemoradiotherapy.
    Radiother Oncol. 2021 Oct 7. pii: S0167-8140(21)08758.
    PubMed     Abstract available


  78. SHI Z, Zhu X, Ke S, Qiu H, et al
    Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: a propensity score matching and landmark analyses.
    Radiother Oncol. 2021 Oct 7. pii: S0167-8140(21)08754.
    PubMed     Abstract available


  79. YAN A, Hanna A, Wilson TG, Deraniyagala R, et al
    Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma.
    Radiother Oncol. 2021 Oct 4. pii: S0167-8140(21)08748.
    PubMed     Abstract available


  80. KANEHIRA T, van Kranen S, Jansen T, Hamming-Vrieze O, et al
    Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients.
    Radiother Oncol. 2021 Oct 4. pii: S0167-8140(21)06738.
    PubMed     Abstract available


    September 2021
  81. HUANG W, Zhang Q, Wu G, Pian Chen P, et al
    DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1alpha, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients.
    Radiother Oncol. 2021 Sep 27. pii: S0167-8140(21)06739.
    PubMed     Abstract available


  82. WAGENAAR D, Schuit E, van der Schaaf A, Langendijk JA, et al
    Can the mean linear energy transfer of organs be directly related to patient toxicities for current head and neck cancer intensity-modulated proton therapy practice?
    Radiother Oncol. 2021 Sep 14. pii: S0167-8140(21)06723.
    PubMed     Abstract available


  83. WANG X, Hobbs B, Gandhi SJ, Muijs CT, et al
    Current Status and Application of Proton Therapy for Esophageal Cancer.
    Radiother Oncol. 2021 Sep 14. pii: S0167-8140(21)06724.
    PubMed     Abstract available


  84. CHOW JCH, Lee A, Bao KKH, Cheung KM, et al
    Cranial neuropathies in advanced nasopharyngeal carcinoma: Neurological recovery after modern radiotherapy and systemic chemotherapy.
    Radiother Oncol. 2021 Sep 7. pii: S0167-8140(21)06716.
    PubMed     Abstract available


    August 2021
  85. KROESE TE, Jairam J, Ruurda JP, Lin SH, et al
    Severe lymphopenia acquired during chemoradiotherapy for esophageal cancer: incidence and external validation of a prediction model.
    Radiother Oncol. 2021 Aug 25. pii: S0167-8140(21)06703.
    PubMed     Abstract available


  86. LIU T, Liu LT, Lin JY, Shen BW, et al
    Management of Suboptimal Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Re-induction Therapy or Direct to Radiotherapy?
    Radiother Oncol. 2021 Aug 25. pii: S0167-8140(21)06704.
    PubMed     Abstract available


  87. MUSHA A, Shimada H, Kubo N, Kawamura H, et al
    Clinical features and dosimetric evaluation of carbon ion radiation-induced osteoradionecrosis of mandible in head and neck tumors.
    Radiother Oncol. 2021;161:205-210.
    PubMed     Abstract available


  88. WENTZEL A, Luciani T, van Dijk LV, Taku N, et al
    Precision association of lymphatic disease spread with radiation-associated toxicity in oropharyngeal squamous carcinomas.
    Radiother Oncol. 2021;161:152-158.
    PubMed     Abstract available


  89. N B P, Ravi KS, Durgapal P
    Discovery of new salivary gland - A substantial histological analysis.
    Radiother Oncol. 2021;161:92-94.
    PubMed     Abstract available


  90. GREGOIRE V, Bauwens L
    Reply to sanguineti regarding the manuscript untitled "Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma".
    Radiother Oncol. 2021;161:253.
    PubMed    


  91. SANGUINETI G
    Re: Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma. Radiother Oncol, 2021. 157: p. 122-129.
    Radiother Oncol. 2021;161:251-252.
    PubMed    


  92. SHARABIANI M, Clementel E, Andratschke N, Collette L, et al
    Independent external validation using the EORTC HNCG-ROG 1219 DAHANCA trial data of NTCP models for acute oral mucositis.
    Radiother Oncol. 2021;161:35-39.
    PubMed     Abstract available


    July 2021
  93. WANG XY, Zhu SY, Wu WJ, Li HJ, et al
    Corrigendum to "Extent of paranasal sinus involvement and its prognostic value in nasopharyngeal carcinoma: Proposed modification in the current UICC/AJCC staging system" [Radiother Oncol 160 (2021) 221-227].
    Radiother Oncol. 2021 Jul 31. pii: S0167-8140(21)06644.
    PubMed    


  94. YANG G, Feng D, Li F, Luo B, et al
    A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma.
    Radiother Oncol. 2021 Jul 31. pii: S0167-8140(21)06667.
    PubMed     Abstract available


  95. PARSAI S, Lei J Qiu R, Qi P, Sedor G, et al
    In Vivo Assessment of the Safety of Standard Fractionation Temporally Feathered Radiation Therapy (TFRT) for Head and Neck Squamous Cell Carcinoma: An R-IDEAL Stage 1/2a First-in-Humans/Feasibility Demonstration of New Technology Implementation.
    Radiother Oncol. 2021 Jul 29. pii: S0167-8140(21)06666.
    PubMed     Abstract available


  96. AL-MAMGANI A, Kessels R, Navran A, Hamming-Vrieze O, et al
    Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes.
    Radiother Oncol. 2021 Jul 23. pii: S0167-8140(21)06659.
    PubMed     Abstract available


  97. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al.
    Radiother Oncol. 2021 Jul 15. pii: S0167-8140(21)06639.
    PubMed    


  98. MUNARETTO TIMM BAIOCCHI J, Fischer-Sgrott F, Baiocchi Neto G
    Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)".
    Radiother Oncol. 2021 Jul 15. pii: S0167-8140(21)06642.
    PubMed    


  99. JO YY, Yu J, Song KJ, Jang JY, et al
    Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: a retrospective study.
    Radiother Oncol. 2021 Jul 12. pii: S0167-8140(21)06643.
    PubMed     Abstract available


  100. BOEKHOFF MR, Defize IL, Borggreve AS, van Hillegersberg R, et al
    An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients.
    Radiother Oncol. 2021 Jul 5. pii: S0167-8140(21)06626.
    PubMed     Abstract available


  101. VAN DER LAAN HP, van der Schaaf A, Van den Bosch L, Korevaar EW, et al
    Quality of life and toxicity guided treatment plan optimisation for head and neck cancer.
    Radiother Oncol. 2021 Jul 5. pii: S0167-8140(21)06623.
    PubMed     Abstract available


  102. CARSUZAA F, Lapeyre M, Gregoire V, Maingon P, et al
    Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus.
    Radiother Oncol. 2021;160:140-147.
    PubMed     Abstract available


  103. CHEN X, Sun S, Bai N, Han K, et al
    A deep learning-based auto-segmentation system for organs-at-risk on whole-body computed tomography images for radiation therapy.
    Radiother Oncol. 2021;160:175-184.
    PubMed     Abstract available


  104. SAMBASIVAN K, Sassoon I, Thavaraj S, Kennedy R, et al
    TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapy.
    Radiother Oncol. 2021;160:54-60.
    PubMed     Abstract available


  105. CAO J, Zhang X, Jiang B, Chen J, et al
    Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.
    Radiother Oncol. 2021;160:32-39.
    PubMed     Abstract available


    June 2021
  106. SUN XS, Xie SY, Luo DH, Liu LT, et al
    Impact of smoking on survival in nasopharyngeal carcinoma: A cohort study with 23,325 patients diagnosed from 1990 to 2016.
    Radiother Oncol. 2021 Jun 25. pii: S0167-8140(21)06612.
    PubMed     Abstract available


  107. DONNELLY O, Goranova R, Nugent M
    Letter to the editor regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)" by Robijns et al. Radiat Oncol. 2021.
    Radiother Oncol. 2021 Jun 15. pii: S0167-8140(21)06579.
    PubMed    


  108. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)".
    Radiother Oncol. 2021 Jun 10. pii: S0167-8140(21)06581.
    PubMed    


  109. JIN YN, Yao JJ, You YF, Cao HJ, et al
    Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study.
    Radiother Oncol. 2021 Jun 8. pii: S0167-8140(21)06575.
    PubMed     Abstract available


  110. DE BREE R, Swartz JE, Bril S, Chargi N, et al
    Skeletal muscle mass measurements using head and neck CT imaging in head and neck cancer patients.
    Radiother Oncol. 2021 Jun 6. pii: S0167-8140(21)06573.
    PubMed    


  111. LALONDE A, Bobic M, Winey B, Verburg J, et al
    Anatomic changes in head and neck intensity-modulated proton therapy: Comparison between robust optimization and online adaptation.
    Radiother Oncol. 2021;159:39-47.
    PubMed     Abstract available


    May 2021
  112. JIANG C, Gong B, Gao H, Zhang T, et al
    Correlation analysis of neck node levels in 960 cases of Nasopharyngeal carcinoma (NPC).
    Radiother Oncol. 2021 May 24. pii: S0167-8140(21)06258.
    PubMed     Abstract available


  113. BOEKHOFF MR, Defize IL, Borggreve AS, van Hillegersberg R, et al
    CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis.
    Radiother Oncol. 2021 May 13. pii: S0167-8140(21)06241.
    PubMed     Abstract available


  114. WANG XY, Zhu SY, Wu WJ, Li HJ, et al
    Extent of Paranasal Sinus Involvement and its Prognostic Value in Nasopharyngeal Carcinoma: Proposed Modification in the Current UICC/AJCC staging system.
    Radiother Oncol. 2021 May 10. pii: S0167-8140(21)06224.
    PubMed     Abstract available


  115. SUN Z, Hu S, Xue Q, Jin L, et al
    Can 3D pseudo-continuous arterial spin labeling perfusion imaging be applied to predict early response to chemoradiotherapy in patients with advanced nasopharyngeal carcinoma?
    Radiother Oncol. 2021 May 2. pii: S0167-8140(21)06214.
    PubMed     Abstract available


  116. CIECIOR W, Ebert N, Borgeaud N, Thames HD, et al
    Sample-size calculation for preclinical dose-response experiments using heterogeneous tumour models.
    Radiother Oncol. 2021;158:262-267.
    PubMed     Abstract available


  117. LAI Y, Zeng X, Zhou K, Zhou X, et al
    End to end intussusception anastomosis decreases the risk of anastomotic leakage after neoadjvant chemoradiation and McKeown oesophagectomy.
    Radiother Oncol. 2021;158:285-292.
    PubMed     Abstract available


  118. HAGUE C, McPartlin A, Lee LW, Hughes C, et al
    An evaluation of MR based deep learning auto-contouring for planning head and neck radiotherapy.
    Radiother Oncol. 2021;158:112-117.
    PubMed     Abstract available


  119. LEE J, Liu SH, Chen JC, Leu YS, et al
    Progressive muscle loss is an independent predictor for survival in locally advanced oral cavity cancer: A longitudinal study.
    Radiother Oncol. 2021;158:83-89.
    PubMed     Abstract available


  120. ZHAO L, Chen S, Chen S, Pang Y, et al
    (68)Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer.
    Radiother Oncol. 2021;158:55-61.
    PubMed     Abstract available


    April 2021
  121. TAMBAS M, der Laan HPV, Rutgers W, van den Hoek JGM, et al
    Development of advanced preselection tools to reduce redundant plan comparisons in model-based selection of head and neck cancer patients for proton therapy.
    Radiother Oncol. 2021 Apr 20. pii: S0167-8140(21)06194.
    PubMed     Abstract available


  122. VAN DER LAAN HP, Van den Bosch L, Schuit E, Steenbakkers RJHM, et al
    aImpact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer.
    Radiother Oncol. 2021 Apr 20. pii: S0167-8140(21)06193.
    PubMed     Abstract available


  123. ELICIN O, Koller Brolese E, Bojaxhiu B, Sermaxhaj B, et al
    The prognostic impact of daytime and seasonality of radiotherapy on head and neck cancer.
    Radiother Oncol. 2021 Apr 10. pii: S0167-8140(21)06185.
    PubMed     Abstract available


  124. ESTEBAN B, Pierre P, Camille S, Pascal P, et al
    Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: a multicentric study using propensity score.
    Radiother Oncol. 2021 Apr 9. pii: S0167-8140(21)06183.
    PubMed     Abstract available


  125. LU ZJ, Liu LT, Sun XS, Guo SS, et al
    Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06175.
    PubMed     Abstract available


  126. YAN JJ, Guo SS, Lin DF, Liu LT, et al
    Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06180.
    PubMed     Abstract available


  127. QIU Y, Guo Z, Lin X, Li J, et al
    Standard radiotherapy for patients with nasopharyngeal carcinoma results in progressive tract-specific brain white matter alterations: A one-year follow-up via diffusion tensor imaging.
    Radiother Oncol. 2021 Apr 8. pii: S0167-8140(21)06179.
    PubMed     Abstract available


  128. ZHANG Y, Feng W, Gao LT, Cai XW, et al
    Long-term follow-up of a phase I/II trial of radiation dose escalation by simultaneous integrated boost for locally advanced esophageal squamous cell carcinoma.
    Radiother Oncol. 2021 Apr 1. pii: S0167-8140(21)06171.
    PubMed     Abstract available


  129. WONG ET, Huang SH, O'Sullivan B, Persaud V, et al
    Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy.
    Radiother Oncol. 2021;157:255-262.
    PubMed     Abstract available


  130. JENSEN GL, Axelrud G, Fink D, Hammonds K, et al
    Improved local control in p16 negative oropharyngeal cancers with hypermethylated MGMT.
    Radiother Oncol. 2021;157:234-240.
    PubMed     Abstract available


  131. BAUWENS L, Baltres A, Fiani DJ, Zrounba P, et al
    Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Radiother Oncol. 2021;157:122-129.
    PubMed     Abstract available


  132. GUNN L, Gilbert J, Nenclares P, Soliman H, et al
    Taste dysfunction following radiotherapy to the head and neck: A systematic review.
    Radiother Oncol. 2021;157:130-140.
    PubMed     Abstract available


  133. MEN K, Chen X, Yang B, Zhu J, et al
    Automatic segmentation of three clinical target volumes in radiotherapy using lifelong learning.
    Radiother Oncol. 2021;157:1-7.
    PubMed     Abstract available


  134. STIEB S, Mohamed ASR, He R, Zhu LL, et al
    Development and validation of a contouring guideline for the taste bud bearing tongue mucosa.
    Radiother Oncol. 2021;157:63-69.
    PubMed     Abstract available


    March 2021
  135. LI G, Jiang Y, Li G, Qiao Q, et al
    Comprehensive analysis of radiosensitivity in head and neck squamous cell carcinoma.
    Radiother Oncol. 2021 Mar 25. pii: S0167-8140(21)06143.
    PubMed     Abstract available


  136. LOSER A, Abel J, Magdalena Kutz L, Krause L, et al
    Head and neck cancer patients under (chemo-)radiotherapy undergoing nutritional intervention: results from the prospective randomized headnut-trial.
    Radiother Oncol. 2021 Mar 22. pii: S0167-8140(21)06145.
    PubMed     Abstract available


  137. RUHLE A, Grosu AL, Wiedenmann N, Stoian R, et al
    Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial.
    Radiother Oncol. 2021 Mar 19. pii: S0167-8140(21)06140.
    PubMed     Abstract available


  138. GROSSBERG AJ, Rock CD, Edwards J, Mohamed ASR, et al
    Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy.
    Radiother Oncol. 2021 Mar 15. pii: S0167-8140(21)06131.
    PubMed     Abstract available


  139. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
    Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
    Radiother Oncol. 2021 Mar 9. pii: S0167-8140(21)06117.
    PubMed     Abstract available


  140. CHEN B, Deng M, Yang C, Dragomir MP, et al
    High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis.
    Radiother Oncol. 2021 Mar 2. pii: S0167-8140(21)06094.
    PubMed     Abstract available


  141. BROLESE EK, Cihoric N, Bojaxhiu B, Sermaxhaj B, et al
    The impact of delivery daytime and seasonality of radiotherapy for head and neck cancer on toxicity burden.
    Radiother Oncol. 2021 Mar 2. pii: S0167-8140(21)06113.
    PubMed     Abstract available


  142. PATEL S, Patel N, Sassoon I, Patel V, et al
    The use of pentoxifylline, tocopherol and clodronate in the management of osteoradionecrosis of the jaws.
    Radiother Oncol. 2021;156:209-216.
    PubMed     Abstract available


  143. AKBABA S, Ruhle A, Rothhaar S, Zamboglou C, et al
    Treatment outcomes of elderly salivary gland cancer patients undergoing radiotherapy - Results from a large multicenter analysis.
    Radiother Oncol. 2021;156:266-274.
    PubMed     Abstract available


  144. THOMAS M, Mortensen HR, Hoffmann L, Moller DS, et al
    Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer.
    Radiother Oncol. 2021;156:102-112.
    PubMed     Abstract available


  145. HOSNI A, Huang SH, Xu W, Su J, et al
    Healthcare resource utilization following unilateral versus bilateral radiation therapy for oropharyngeal carcinoma.
    Radiother Oncol. 2021;156:95-101.
    PubMed     Abstract available


    February 2021
  146. HUANG TW, Shao CH, Chiang CC
    Response to the letter to the editor "Exercise therapy for cancer treatment-induced trismus in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials regards to Chiu et al."
    Radiother Oncol. 2021 Feb 26. pii: S0167-8140(21)06086.
    PubMed    


  147. CHIU YH, Wang TG
    Letter to the editor regarding Shao et al., Exercise therapy for cancer treatment-induced trismus in patients with head and neck cancer: A systematic review and meta-analysis of randomized controlled trials.
    Radiother Oncol. 2021 Feb 26. pii: S0167-8140(21)06088.
    PubMed    


  148. FAN WJ, Teng F, Liu G, Zhao DW, et al
    Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma.
    Radiother Oncol. 2021 Feb 12. pii: S0167-8140(21)06050.
    PubMed     Abstract available


  149. NIE D, Wang X, Sun M, Feng Z, et al
    The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: a systematic review and meta-analysis.
    Radiother Oncol. 2021 Feb 12. pii: S0167-8140(21)06047.
    PubMed     Abstract available


  150. YANG ES, Deutsch E, Mehmet A, Fayette J, et al
    A phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma.
    Radiother Oncol. 2021 Feb 9. pii: S0167-8140(21)06040.
    PubMed     Abstract available


  151. VAN AKEN ESM, Paul van der Laan H, Bijl HP, Van den Bosch L, et al
    Risk of ischaemic cerebrovascular events in head and neck cancer patients is associated with carotid artery radiation dose.
    Radiother Oncol. 2021 Feb 2. pii: S0167-8140(21)06023.
    PubMed     Abstract available


  152. VAN DEN BOSCH L, van der Schaaf A, Paul van der Laan H, Hoebers FJP, et al
    Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: a new concept for individually optimised treatment.
    Radiother Oncol. 2021 Feb 2. pii: S0167-8140(21)06021.
    PubMed     Abstract available


  153. DIETRICH A, Andreeff M, Koi L, Bergmann R, et al
    Radiotherapy enhances uptake and efficacy of (90)Y-cetuximab: A preclinical trial.
    Radiother Oncol. 2021;155:285-292.
    PubMed     Abstract available


  154. MICHAELIDOU A, Adjogatse D, Suh Y, Pike L, et al
    18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO).
    Radiother Oncol. 2021;155:261-268.
    PubMed     Abstract available


  155. ROSEN BS, Wilkie JR, Sun Y, Ibrahim M, et al
    CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Radiother Oncol. 2021;155:174-181.
    PubMed     Abstract available


    January 2021
  156. MAO Y, Wang S, Lydiatt W, Shah JP, et al
    Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems.
    Radiother Oncol. 2021 Jan 28. pii: S0167-8140(21)00015.
    PubMed     Abstract available


  157. LACAS B, Carmel A, Landais C, Wong SJ, et al
    Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.
    Radiother Oncol. 2021 Jan 27. pii: S0167-8140(21)00013.
    PubMed     Abstract available


  158. WEN DW, Lin L, Mao YP, Chen CY, et al
    Comparison of Normal Tissue Complication Probability (NTCP) Models Using Machine Learning for Predicting Temporal Lobe Injury after Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma: a Large Registry-Based Retrospective Study from China.
    Radiother Oncol. 2021 Jan 20. pii: S0167-8140(21)00008.
    PubMed     Abstract available


  159. HUANG TT, Li SH, Chen YH, Lu HI, et al
    Definitive chemoradiotherapy for clinical T4b esophageal cancer - treatment outcomes, failure patterns, and prognostic factors.
    Radiother Oncol. 2021 Jan 19. pii: S0167-8140(21)00007.
    PubMed     Abstract available


  160. GUO Q, Zheng Y, Lin J, Xu Y, et al
    Modified Reduced-volume Intensity-modulated radiation therapy in Non-metastatic Nasopharyngeal Carcinoma: A Prospective Observation Series.
    Radiother Oncol. 2021 Jan 5. pii: S0167-8140(20)31262.
    PubMed     Abstract available


  161. HOSNI A, Chiu K, Huang SH, Xu W, et al
    Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach.
    Radiother Oncol. 2021;154:70-75.
    PubMed     Abstract available


  162. NARAYAN RK, Kumari C, Panchal P, Ghosh SK, et al
    A macroscopic salivary gland and a potential organ or simply tubarial sero-mucinous glands?
    Radiother Oncol. 2021;154:324-325.
    PubMed    


  163. YAN D, Chen S, Krauss DJ, Deraniyagala R, et al
    Inter/intra-tumoral dose response variations assessed using FDG-PET/CT feedback images: Impact on tumor control and treatment dose prescription.
    Radiother Oncol. 2021;154:235-242.
    PubMed     Abstract available


  164. VALSTAR MH, de Bakker BS, Steenbakkers RJHM, de Jong KH, et al
    The tubarial salivary glands: A potential new organ at risk for radiotherapy.
    Radiother Oncol. 2021;154:292-298.
    PubMed     Abstract available


  165. WAGENAAR D, Kierkels RGJ, van der Schaaf A, Meijers A, et al
    Head and neck IMPT probabilistic dose accumulation: Feasibility of a 2 mm setup uncertainty setting.
    Radiother Oncol. 2021;154:45-52.
    PubMed     Abstract available


  166. QIU X, Xu T, Li M, Fei Z, et al
    Response to Chai' letter: What caused the difference in prognosis among different physicians?
    Radiother Oncol. 2021;154:e20-e21.
    PubMed    


    December 2020
  167. FAN KH, Yeh CH, Hung SP, Kang CJ, et al
    Prognostic value of radiologic extranodal extension in patients with hypopharyngeal cancer treated with primary chemoradiation.
    Radiother Oncol. 2020 Dec 29. pii: S0167-8140(20)31255.
    PubMed     Abstract available


  168. XIANG M, Gensheimer MF, Pollom EL, Holsinger FC, et al
    Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors.
    Radiother Oncol. 2020 Dec 28. pii: S0167-8140(20)31251.
    PubMed     Abstract available


  169. LIANG SB, Chen LS, Chen HY, Yang XL, et al
    Prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma: a retrospective study.
    Radiother Oncol. 2020 Dec 10. pii: S0167-8140(20)31231.
    PubMed     Abstract available


  170. VAN DER VEEN J, Willems S, Bollen H, Maes F, et al
    Deep learning for elective neck delineation: More consistent and time efficient.
    Radiother Oncol. 2020;153:180-188.
    PubMed     Abstract available


    November 2020
  171. RUHLE A, Stromberger C, Haehl E, Senger C, et al
    Development and validation of a novel prognostic score for elderly head-and-neck cancer patients undergoing radiotherapy or chemoradiation.
    Radiother Oncol. 2020 Nov 24. pii: S0167-8140(20)31193.
    PubMed     Abstract available


  172. LIANG SB, Chen LS, Yang XL, Chen DM, et al
    Influence of Tumor Necrosis on Treatment Sensitivity and Long-term Survival in Nasopharyngeal Carcinoma.
    Radiother Oncol. 2020 Nov 17. pii: S0167-8140(20)31165.
    PubMed     Abstract available


  173. HIROSE K, Konno A, Hiratsuka J, Yoshimoto S, et al
    Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan((10)B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial.
    Radiother Oncol. 2020 Nov 10. pii: S0167-8140(20)30890.
    PubMed     Abstract available


    October 2020
  174. CHEN NB, Li QW, Li S, Guo SP, et al
    Docetaxel and nedaplatin twice a week with concurrent definitive radiotherapy in inoperable esophageal squamous cell carcinoma: a phase I trial (GASTO-1021).
    Radiother Oncol. 2020 Oct 31. pii: S0167-8140(20)30882.
    PubMed     Abstract available


  175. ZSCHAECK S, Zophel K, Seidlitz A, Zips D, et al
    Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.
    Radiother Oncol. 2020;155:204-211.
    PubMed     Abstract available


  176. VAN ROSSUM PSN, Jeene PM, Rozema T, Braam PM, et al
    Patient-reported outcomes after external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: a matched comparison of two prospective trials.
    Radiother Oncol. 2020 Oct 13. pii: S0167-8140(20)30845.
    PubMed     Abstract available


  177. LUO WJ, Zou WQ, Liang SB, Chen L, et al
    Combining tumor response and personalized risk assessment: potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Radiother Oncol. 2020 Oct 8. pii: S0167-8140(20)30841.
    PubMed     Abstract available


  178. IORIO GC, Ricardi U, Franco P
    The importance of IL-6 blockade beyond the COVID-19 pandemic: Consideration for cancer care.
    Radiother Oncol. 2020;151:24-25.
    PubMed    


  179. LIU WC, Liu HE, Kao YW, Qin L, et al
    Definitive radiotherapy or surgery for early oral squamous cell carcinoma in old and very old patients: A propensity-score-matched, nationwide, population-based cohort study.
    Radiother Oncol. 2020;151:214-221.
    PubMed     Abstract available


  180. HAMILTON SN, Urban R, Liu A, Chau N, et al
    Population-based outcomes by immunosuppressed status in patients undergoing radiotherapy for oropharyngeal cancer.
    Radiother Oncol. 2020;151:110-117.
    PubMed     Abstract available


  181. LAI TY, Yeh CM, Hu YW, Liu CJ, et al
    Hospital volume and physician volume in association with survival in patients with nasopharyngeal cancer after radiation therapy.
    Radiother Oncol. 2020;151:190-199.
    PubMed     Abstract available


  182. LERCH S, Berthold S, Ziemann F, Dreffke K, et al
    HPV-positive HNSCC cell lines show strongly enhanced radiosensitivity after photon but not after carbon ion irradiation.
    Radiother Oncol. 2020;151:134-140.
    PubMed     Abstract available


  183. SHARMA MB, Jensen K, Urbak SF, Funding M, et al
    A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer.
    Radiother Oncol. 2020;151:58-65.
    PubMed     Abstract available


  184. ENGESETH GM, Stieb S, Mohamed ASR, He R, et al
    Outcomes and patterns of radiation associated brain image changes after proton therapy for head and neck skull base cancers.
    Radiother Oncol. 2020;151:119-125.
    PubMed     Abstract available


  185. ANAKOTTA RM, van der Laan HP, Visser S, Ribeiro CO, et al
    Weekly robustness evaluation of intensity-modulated proton therapy for oesophageal cancer.
    Radiother Oncol. 2020;151:66-72.
    PubMed     Abstract available


    September 2020
  186. LI J, Wen Y, Xiang Z, Du H, et al
    Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer.
    Radiother Oncol. 2020 Sep 24. pii: S0167-8140(20)30817.
    PubMed     Abstract available


  187. LIN CH, Chou WC, Wu YY, Lin CY, et al
    Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study.
    Radiother Oncol. 2020 Sep 14. pii: S0167-8140(20)30784.
    PubMed     Abstract available


  188. GARCIA-CONSUEGRA A, Gimeno Morales M, Cambeiro M, Tagliaferri L, et al
    Dose Volume Histogram Constraints in Patients with Head and Neck Cancer treated with Surgery and Adjuvant HDR Brachytherapy: A Proposal of the Head and Neck and Skin GEC ESTRO Working Group.
    Radiother Oncol. 2020 Sep 14. pii: S0167-8140(20)30787.
    PubMed     Abstract available


  189. HU Y, Xie C, Yang H, Wk Ho J, et al
    Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma.
    Radiother Oncol. 2020 Sep 14. pii: S0167-8140(20)30786.
    PubMed     Abstract available


  190. LE GUEVELOU J, Bastit V, Marcy PY, Lasne-Cardon A, et al
    Flap Delineation Guidelines in Postoperative Head and Neck Radiation Therapy for head and neck cancers.
    Radiother Oncol. 2020 Sep 2. pii: S0167-8140(20)30754.
    PubMed     Abstract available


  191. DAHELE M, Tol JP, Vergeer MR, Jansen F, et al
    Is the introduction of more advanced radiotherapy techniques for locally-advanced head and neck cancer associated with improved quality of life and reduced symptom burden?
    Radiother Oncol. 2020 Sep 2. pii: S0167-8140(20)30755.
    PubMed     Abstract available


  192. SHAO CH, Chiang CC, Huang TW
    Exercise therapy for cancer therapy-induced trismus in patients with head and neck cancer: a systematic review and meta-analysis of randomized controlled trials.
    Radiother Oncol. 2020 Sep 2. pii: S0167-8140(20)30753.
    PubMed     Abstract available


    August 2020
  193. XU C, Zhang Y, Chen L, Li WF, et al
    Association between outcome disparities and pragmatic features related to clinical trial and real-world settings in nasopharyngeal carcinoma: A population-based retrospective cohort study, 2006-2016.
    Radiother Oncol. 2020 Aug 28. pii: S0167-8140(20)30737.
    PubMed     Abstract available


  194. KANAYAMA N, Otozai S, Yoshii T, Toratani M, et al
    Death unrelated to cancer and death from aspiration pneumonia after definitive radiotherapy for head and neck cancer.
    Radiother Oncol. 2020 Aug 28. pii: S0167-8140(20)30733.
    PubMed     Abstract available


  195. SAKSO M, Mortensen LS, Primdahl H, Johansen J, et al
    Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224).
    Radiother Oncol. 2020 Aug 14. pii: S0167-8140(20)30724.
    PubMed     Abstract available


  196. DANIELS CP, Yu-Hao Liu H, Bernard A, Williams C, et al
    The declining role of post-treatment neck dissection in human papillomavirus-associated oropharyngeal cancer.
    Radiother Oncol. 2020 Aug 13. pii: S0167-8140(20)30722.
    PubMed     Abstract available


  197. JENSEN K, Friborg J, Hansen CR, Samsoe E, et al
    The danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines.
    Radiother Oncol. 2020 Aug 8. pii: S0167-8140(20)30685.
    PubMed    


  198. TAMBAS M, J H M Steenbakkers R, van der Laan HP, Wolters AM, et al
    First experience with model-based selection of head and neck cancer patients for proton therapy.
    Radiother Oncol. 2020 Aug 5. pii: S0167-8140(20)30715.
    PubMed     Abstract available


  199. BEUKEMA JC, Kawaguchi Y, Sijtsema NM, Zhai TT, et al
    Can we safely reduce the radiation dose to the heart while compromising the dose to the lungs in oesophageal cancer patients?
    Radiother Oncol. 2020;149:222-227.
    PubMed     Abstract available


  200. GOTTGENS EL, Bussink J, Ansems M, Hammond EM, et al
    AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC.
    Radiother Oncol. 2020;149:1-7.
    PubMed     Abstract available


    July 2020
  201. THOMSON DJ, Palma D, Guckenberger M, Balermpas P, et al
    Reprint of: Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement.
    Radiother Oncol. 2020 Jul 27. pii: S0167-8140(20)30200.
    PubMed     Abstract available


  202. HILKE FJ, Muyas F, Admard J, Kootz B, et al
    Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy.
    Radiother Oncol. 2020 Jul 17. pii: S0167-8140(20)30421.
    PubMed     Abstract available


  203. MA H, Liang S, Cui C, Zhang Y, et al
    Prognostic significance of quantitative metastatic lymph node burden on magnetic resonance imaging in nasopharyngeal carcinoma:a retrospective study of 1224 patients from two centers.
    Radiother Oncol. 2020 Jul 14. pii: S0167-8140(20)30416.
    PubMed     Abstract available


  204. JOURNY N, Schonfeld SJ, Hauptmann M, Roberti S, et al
    Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer.
    Radiother Oncol. 2020 Jul 14. pii: S0167-8140(20)30415.
    PubMed     Abstract available


  205. HONG RIM C
    Letter to the editor regarding the article "Selection of a high-level physician may help improve outcomes of nasopharyngeal carcinoma" by Fei et al.
    Radiother Oncol. 2020 Jul 13. pii: S0167-8140(20)30413.
    PubMed    


  206. CELLINI F, Antonietta Gambacorta M, Carlo Mattiucci G, Valentini V, et al
    Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond.
    Radiother Oncol. 2020 Jul 13. pii: S0167-8140(20)30398.
    PubMed    


  207. TCHELEBI LT, Goodman K
    Response to, "Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of COVID-19 and beyond".
    Radiother Oncol. 2020 Jul 13. pii: S0167-8140(20)30404.
    PubMed    


  208. ZHONG LZ, Fang XL, Dong D, Peng H, et al
    A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0.
    Radiother Oncol. 2020 Jul 4. pii: S0167-8140(20)30387.
    PubMed     Abstract available


  209. PENG Y, Chen S, Qin A, Chen M, et al
    Magnetic resonance-based synthetic computed tomography images generated using generative adversarial networks for nasopharyngeal carcinoma radiotherapy treatment planning.
    Radiother Oncol. 2020 Jul 2. pii: S0167-8140(20)30385.
    PubMed     Abstract available


  210. WENTZEL A, Hanula P, van Dijk LV, Elgohari B, et al
    Precision toxicity correlates of tumor spatial proximity to organs at risk in cancer patients receiving intensity-modulated radiotherapy.
    Radiother Oncol. 2020;148:245-251.
    PubMed     Abstract available


  211. VAN DEN BOSCH L, Schuit E, van der Laan HP, Reitsma JB, et al
    Key challenges in normal tissue complication probability model development and validation: towards a comprehensive strategy.
    Radiother Oncol. 2020;148:151-156.
    PubMed     Abstract available


  212. KAANDERS JHAM, van den Bosch S, Dijkema T, Al-Mamgani A, et al
    Advances in cancer imaging require renewed radiotherapy dose and target volume concepts.
    Radiother Oncol. 2020;148:140-142.
    PubMed     Abstract available


  213. GRANT SR, Hutcheson KA, Ye R, Garden AS, et al
    Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer.
    Radiother Oncol. 2020;148:133-139.
    PubMed     Abstract available


  214. SAKSO M, Jensen K, Andersen M, Hansen CR, et al
    DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx,
    Radiother Oncol. 2020;148:65-72.
    PubMed     Abstract available


  215. WILKIE JR, Mierzwa ML, Casper KA, Mayo CS, et al
    Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metrics.
    Radiother Oncol. 2020;148:30-37.
    PubMed     Abstract available


    June 2020
  216. SHAHID IQBAL M, Kovarik J, Kelly C
    Challenges in conducting large randomised control trials of palliative radiotherapy in head and neck cancer.
    Radiother Oncol. 2020 Jun 27. pii: S0167-8140(20)30351.
    PubMed    


  217. RULACH R, Zhou S, Paterson C
    Letter to editor regarding Urban et al., FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status.
    Radiother Oncol. 2020 Jun 24. pii: S0167-8140(20)30357.
    PubMed    


  218. JIN J, Guo Y, Dong X, Liu J, et al
    Methylation-associated silencing of miR-193b improves the radiotherapy sensitivity of esophageal cancer cells by targeting cyclin D1 in areas with zinc deficiency.
    Radiother Oncol. 2020 Jun 21. pii: S0167-8140(20)30347.
    PubMed     Abstract available


  219. WIEDENMANN N, Grosu AL, Buchert M, Rischke HC, et al
    The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer.
    Radiother Oncol. 2020 Jun 13. pii: S0167-8140(20)30336.
    PubMed     Abstract available


  220. LAN X, Chan JYK, Pu JJ, Qiao W, et al
    Saliva electrolyte analysis and xerostomia-related quality of life in nasopharyngeal carcinoma patients following intensity-modulated radiation therapy.
    Radiother Oncol. 2020 Jun 13. pii: S0167-8140(20)30339.
    PubMed     Abstract available


  221. RIESTERER O, Pruschy M, Bender S, Sharma A, et al
    Consolidation cetuximab after concurrent triplet radiochemotherapy + cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
    Radiother Oncol. 2020 Jun 12. pii: S0167-8140(20)30334.
    PubMed     Abstract available


  222. VAN DER HEIJDEN M, Essers PBM, Verhagen CVM, Willems SM, et al
    Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy.
    Radiother Oncol. 2020;147:186-194.
    PubMed     Abstract available


  223. MANZAR GS, Lester SC, Routman DM, Harmsen WS, et al
    Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.
    Radiother Oncol. 2020;147:64-74.
    PubMed     Abstract available


  224. HANSEN CR, Bertelsen A, Zukauskaite R, Johnsen L, et al
    Prediction of radiation-induced mucositis of H&N cancer patients based on a large patient cohort.
    Radiother Oncol. 2020;147:15-21.
    PubMed     Abstract available


    May 2020
  225. LAN K, Zhu J, Zhang J, Zhou S, et al
    Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy.
    Radiother Oncol. 2020 May 28. pii: S0167-8140(20)30292.
    PubMed     Abstract available


  226. SO TH, Lam KO
    The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy: Asian perspectives in the immunotherapy era.
    Radiother Oncol. 2020 May 19. pii: S0167-8140(20)30281.
    PubMed    


  227. TINUSZ B, Soos A, Hegyi P, Sarlos P, et al
    Efficacy and safety of stenting and additional oncological treatment versus stenting alone in unresectable esophageal cancer: a meta-analysis and systematic review.
    Radiother Oncol. 2020 May 15. pii: S0167-8140(20)30268.
    PubMed     Abstract available


  228. ZSCHAECK S, Lock S, Hofheinz F, Zips D, et al
    Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy.
    Radiother Oncol. 2020 May 14. pii: S0167-8140(20)30275.
    PubMed     Abstract available


  229. TAO Y, Auperin A, Blanchard P, Alfonsi M, et al
    Concurrent cisplatin and Dose escalation with Intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.
    Radiother Oncol. 2020 May 14. pii: S0167-8140(20)30274.
    PubMed     Abstract available


  230. AL-MAMGANI A, Kessels R, Verhoef CG, Navran A, et al
    Randomized controlled trial to identify the optimal radiotherapy scheme for palliative treatment of incurable head and neck squamous cell carcinoma.
    Radiother Oncol. 2020 May 14. pii: S0167-8140(20)30273.
    PubMed     Abstract available


    April 2020
  231. ANDERSON JL, Newman NB, Anderson C, Sherry AD, et al
    Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer.
    Radiother Oncol. 2020 Apr 11. pii: S0167-8140(19)33508.
    PubMed     Abstract available


  232. ZHOU S, Huang H, Chen Q, Tan KS, et al
    Long-term defects of nasal epithelium barrier functions in patients with nasopharyngeal carcinoma post chemo-radiotherapy.
    Radiother Oncol. 2020;148:116-125.
    PubMed     Abstract available


  233. VAN RIJN-DEKKER MI, van den Bosch L, van den Hoek JGM, Bijl HP, et al
    Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy.
    Radiother Oncol. 2020;147:103-110.
    PubMed     Abstract available


  234. URBAN R, Godoy T, Olson R, Wu J, et al
    FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status.
    Radiother Oncol. 2020;148:14-20.
    PubMed     Abstract available


  235. VISCHIONI B, Dhanireddy B, Severo C, Bonora M, et al
    Reirradiation of salivary gland tumors with carbon ion radiotherapy at CNAO.
    Radiother Oncol. 2020;145:172-177.
    PubMed     Abstract available


  236. DE FELICE F, Bird T, Michaelidou A, Thavaraj S, et al
    Radical (chemo)radiotherapy in oropharyngeal squamous cell carcinoma: Comparison of TNM 7th and 8th staging systems.
    Radiother Oncol. 2020;145:146-153.
    PubMed     Abstract available


  237. NG SP, Bahig H, Jethanandani A, Pollard C, et al
    Lymphopenia during radiotherapy in patients with oropharyngeal cancer.
    Radiother Oncol. 2020;145:95-100.
    PubMed     Abstract available


    March 2020
  238. DE VEIJ MESTDAGH PD, Walraven I, Vogel WV, Schreuder WH, et al
    SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach.
    Radiother Oncol. 2020;147:56-63.
    PubMed     Abstract available


  239. FEI Z, Qiu X, Li Y, Huang Y, et al
    Selection of a high-level physician may help improve outcomes of nasopharyngeal carcinoma.
    Radiother Oncol. 2020;147:130-135.
    PubMed     Abstract available


  240. BOEKHOFF MR, Defize IL, Borggreve AS, Takahashi N, et al
    3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy.
    Radiother Oncol. 2020;147:1-7.
    PubMed     Abstract available


  241. BEDDOK A, Vela A, Calugaru V, Tessonnier T, et al
    Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges.
    Radiother Oncol. 2020;147:30-39.
    PubMed     Abstract available


  242. DE FELICE F, Polimeni A, Valentini V
    The impact of Coronavirus (COVID-19) on head and neck cancer patients' care.
    Radiother Oncol. 2020;147:84-85.
    PubMed    


  243. WONG J, Fong A, McVicar N, Smith S, et al
    Comparing deep learning-based auto-segmentation of organs at risk and clinical target volumes to expert inter-observer variability in radiotherapy planning.
    Radiother Oncol. 2020;144:152-158.
    PubMed     Abstract available


  244. HUANG SH, O'Sullivan B, Su J, Bartlett E, et al
    Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.
    Radiother Oncol. 2020;144:13-22.
    PubMed     Abstract available


    January 2020
  245. KAAE JK, Stenfeldt L, Hyrup B, Brink C, et al
    A randomized phase III trial for alleviating radiation-induced xerostomia with chewing gum.
    Radiother Oncol. 2020;142:72-78.
    PubMed     Abstract available


  246. VOLLENBROCK SE, Voncken FEM, Bartels LW, Beets-Tan RGH, et al
    Diffusion-weighted MRI with ADC mapping for response prediction and assessment of oesophageal cancer: A systematic review.
    Radiother Oncol. 2020;142:17-26.
    PubMed     Abstract available


  247. VAN DIJK LV, Van den Bosch L, Aljabar P, Peressutti D, et al
    Improving automatic delineation for head and neck organs at risk by Deep Learning Contouring.
    Radiother Oncol. 2020;142:115-123.
    PubMed     Abstract available


  248. NIYAZI M, Niemierko A, Paganetti H, Sohn M, et al
    Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.
    Radiother Oncol. 2020;142:154-161.
    PubMed     Abstract available


  249. IYIZOBA-EBOZUE Z, Murray LJ, Arunsingh M, Vaidyanathan S, et al
    Incidence and patterns of retropharyngeal lymph node involvement in oropharyngeal carcinoma.
    Radiother Oncol. 2020;142:92-99.
    PubMed     Abstract available


  250. BAGLEY AF, Ye R, Garden AS, Gunn GB, et al
    Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy.
    Radiother Oncol. 2020;142:133-139.
    PubMed     Abstract available


    July 2019
  251. RIBEIRO CO, Meijers A, Korevaar EW, Muijs CT, et al
    Comprehensive 4D robustness evaluation for pencil beam scanned proton plans.
    Radiother Oncol. 2019;136:185-189.
    PubMed     Abstract available


  252. HOFFMANN L, Poulsen PR, Ravkilde T, Bertholet J, et al
    Setup strategies and uncertainties in esophageal radiotherapy based on detailed intra- and interfractional tumor motion mapping.
    Radiother Oncol. 2019;136:161-168.
    PubMed     Abstract available


  253. ROWELL NP
    The role of external beam radiotherapy in the management of medullary carcinoma of the thyroid: A systematic review.
    Radiother Oncol. 2019;136:113-120.
    PubMed     Abstract available


    May 2019
  254. BRECHT S, Boda-Heggemann J, Budjan J, Siebenlist K, et al
    Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT).
    Radiother Oncol. 2019;134:166-177.
    PubMed     Abstract available


  255. HOSNI A, Huang SH, Chiu K, Xu W, et al
    Validation of distant metastases risk-groups in oral cavity squamous cell carcinoma patients treated with postoperative intensity-modulated radiotherapy.
    Radiother Oncol. 2019;134:10-16.
    PubMed     Abstract available


  256. BIAU J, Lapeyre M, Troussier I, Budach W, et al
    Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update.
    Radiother Oncol. 2019;134:1-9.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: